U.S. Healthcare Services Stock News

The Morning Bull - US Market Morning Update Wednesday, Sep, 2 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.5% and Nasdaq-100 futures off nearly 0.9%. The main pressure is coming from a jump in global government bond yields, as UK and European 10-year bonds move to multi year highs and the main German government bond trades above 3.3%. Higher yields mean borrowing costs stay tough for households and companies. At the same time, manufacturing...

Recently, Monolithic Power Systems reported strong momentum in power management solutions tied to AI infrastructure, cloud computing, and networking, supported by a growing pipeline of AI server, optical module, and data center design wins. The company’s ongoing expansion into AI-focused power solutions and broader industrial and automotive applications underlines how power management chips are becoming central to the AI hardware ecosystem. We’ll now examine how this AI-driven demand for...

Oil near $95 to $97, rising bond yields and a sharp risk off mood have put global markets on edge, yet they have also pushed integrated energy and refining stocks into the spotlight. These companies sit at the crossroads of crude prices, fuel demand and dividend income, so their moves can matter for any portfolio. This article walks through 3 stocks from our Global Integrated Energy & Refining Leaders screener that appear positively exposed to the latest Middle East shock, and explains how...

Recent Share Performance and Business Scale Mohawk Industries (MHK) has drawn attention after recent share price moves, with the stock last closing at US$125.04. Investors are weighing this level against the company’s current size and operating footprint. The company reports annual revenue of US$11.18b and net income of US$464.1m, supported by operations across three flooring segments in the United States and international markets. Reported annual revenue and net income growth figures provide...

Tariff refunds worth over $132b are stuck in limbo, and that kind of uncertainty can be a real stress test for small and mid sized businesses that rely on imports. When working capital gets squeezed, lenders that understand this pressure can move from background players to the center of the story. This article walks through three stocks exposed to this refund saga and explains why they may matter for your watchlist right now. The three stocks below are just a sample pulled from a much larger...

Conference appearance puts Morgan Stanley stock back in focus Morgan Stanley (MS) is drawing fresh investor attention ahead of its participation in the ABN AMRO Bank, FIG Capital and Investor Engagement Conference scheduled for August 27, 2026. At a share price of $211.04, Morgan Stanley has seen short-term share price momentum soften, with the 7-day share price return down 2.64%, even as the year-to-date share price return of 16.02% and 1-year total shareholder return of 44.99% reflect...

On 31 August 2026, Ascendis Pharma A/S announced a binding global settlement and license agreement with BioMarin Pharmaceutical, granting Ascendis a non-exclusive, worldwide, royalty-bearing license to continue developing and commercializing navepegritide-related products, while both companies agreed to dismiss all related legal proceedings and BioMarin waived certain regulatory rights and exclusivities. Under this deal, BioMarin stands to receive meaningful royalties on YUVIWEL and other...

In its past Q2 report, Bruker posted revenues of US$838.5 million, a 5.2% year-on-year increase that still came in 1.9% below analyst estimates, and it updated full-year revenue guidance slightly under consensus expectations. This combination of modest growth and softer guidance stood out because peers in the research tools and consumables subsector generally exceeded forecasts, highlighting company-specific execution and demand challenges. Next, we’ll examine how Bruker’s revenue miss...

Coforge Limited’s expanded partnership with Pegasystems (PEGA) puts fresh attention on how this enterprise software stock is positioned in AI-driven workflow automation and customer engagement, especially as joint Pega-powered offerings reach more global clients. The recent Coforge agreement comes as Pegasystems trades at US$36.68, with a 7.88% 7 day share price return and a 20.07% 30 day share price return suggesting improving near term momentum. This is despite a year to date share price...

With markets now pricing a 77% chance of a U.S. Fed rate hike this year, investors who rely on steady income stocks are suddenly rethinking what higher borrowing costs could mean for their portfolios. Rate sensitive sectors can come under pressure, but they can also create mispriced opportunities. This article walks through three stocks from our utilities and REITs screener that appear positively exposed to the latest Fed narrative. The three stocks highlighted below are just a starting...

Why Applied Optoelectronics raised fresh capital and expanded in Houston The trigger for Applied Optoelectronics (AAOI) stock right now is a twin move: a US$600 million at-the-market equity program and new long-term leases for two large Houston manufacturing and warehouse facilities. These decisions matter for you because they shape how the company may handle rising demand, manage capacity constraints and balance dilution risk. Both the funding and the leases introduce new obligations that...

In the past quarter, Saia reported record second-quarter revenue, tonnage and shipments, with earnings per share coming in above analyst estimates thanks to network growth and disciplined execution. Despite this operational strength, the results highlighted how expectations around Saia’s role in an expanding e-commerce and global trade ecosystem are becoming increasingly central to its long-term outlook. We’ll now examine how Saia’s record tonnage and shipment volumes may influence the...

O-I Glass (OI) has announced an investment to upgrade the furnace and manufacturing equipment at its Muskogee, Oklahoma, plant, supported by a $2 million award from the Oklahoma Department of Commerce. For investors, this investment comes after a tough stretch for O-I Glass, with the share price down 53.7% year to date and the 1-year total shareholder return falling 45.2%. The 3-year total shareholder return has declined 63.9%, suggesting sentiment has weakened despite recent operational...

F5 recently announced enhancements to its AI-powered web application firewall and virtual patching tools, adding anomaly detection, agentic threat intelligence, and tighter integration across its Distributed Cloud and BIG-IP platforms to help customers counter emerging AI-driven and zero-day threats in real time. A key implication is that F5 is embedding more self-learning, inline machine learning and automated virtual patching directly into its application delivery footprint, potentially...

In the past quarter, AXIS Capital Holdings reported Q2 results that fell short of analyst expectations on revenue, net premiums earned, and EPS, reflecting a weaker-than-anticipated performance. The underwhelming quarter highlights how sensitive AXIS remains to broader reinsurance sector conditions, where earnings can swing with catastrophe losses and capital flows. Next, we will examine how AXIS’s Q2 earnings miss may influence its investment narrative built around specialty insurance...

DaVita (DVA) has entered a new value based care agreement with Humana to manage Medicare Advantage members with earlier stage chronic kidney disease, extending their existing partnership beyond end stage care. Against this backdrop, DaVita’s share price has eased in the short term, with a 30 day share price return of down 26.64%. However, the year to date share price return is 53.82% and the 3 year total shareholder return is 82.25%, suggesting that longer term momentum remains stronger than...

Riverwater Partners has recently taken a stake in The Middleby Corporation after the company reported its strongest organic growth in two years, announced a planned spin-off of its food processing business, and repurchased nearly 5% of its shares outstanding in a single quarter. This combination of portfolio reshaping and aggressive buybacks is reshuffling how investors think about the value of Middleby’s core operations versus its food processing arm. We’ll now examine how the planned food...

Dividend announcement puts income focus on Brookfield Infrastructure Partners Brookfield Infrastructure Partners (NYSE:BIP) recently declared a total dividend of US$0.46 per unit, with an ex dividend date of 31 August 2026, drawing attention to the stock’s income profile for unitholders. Brookfield Infrastructure Partners’ recent dividend news comes as the stock trades at US$37.11, after the share price declined 11.14% over the past 30 days and 4.40% over 90 days, while total shareholder...

ResMed (RMD) is back in focus after Frazier Healthcare Partners completed its acquisition of MatrixCare, the company’s residential care software subsidiary, with Jonathan Lujan appointed as MatrixCare’s new chief executive officer. ResMed’s latest move comes after a mixed year for investors, with the share price down 5.49% year to date but showing a 24.08% 90 day share price return and a 54.84% total shareholder return over three years. However, the one year total shareholder return declined...

Kura Oncology recently announced that management will present at three major September 2026 healthcare investor conferences, while continuing to develop precision oncology therapies including FDA-approved KOMZIFTI (ziftomenib) for relapsed or refractory NPM1-mutated acute myeloid leukemia. A recent upgrade of Kura Oncology to a Zacks Rank #2, driven by rising earnings estimates, highlights shifting analyst expectations for its business outlook. We’ll now examine how the Zacks...

With the Fed funds rate still in the 3.50% to 3.75% range and banks keeping a tighter grip on lending, dealmaking is tilting toward buyers and advisors that can handle higher financing costs and focus on resilient cash flow. That shift is creating a fresh set of potential winners and laggards. This article profiles 3 U.S. Middle-Market M&A Advisors and Deal Services stocks that appear most exposed to these trends. The stocks covered below are just a starting sample, and the full screen...

Royalty Pharma recently agreed to pay Zealand Pharma US$100,000,000 for rights to future royalties and milestones tied to rusfertide, an experimental polycythemia vera treatment with an FDA decision previously guided for the third quarter of 2026. This deal adds a new late-stage, specialty-therapy royalty stream to Royalty Pharma’s portfolio, aligning with its focus on broadening exposure to innovative, high‑value medicines. We’ll now examine how acquiring future rusfertide royalties,...

In August 2026, Travelling The Fairways International Ltd. announced it had chosen Flywire as its exclusive payments partner across its UK and Ireland golf tour operations, using Flywire’s platform to handle multi-currency, cross-border guest payments and improve transparency for international golfers. The deal highlights how Flywire’s sector-focused payments software can replace large general-purpose processors by cutting costs, simplifying tax reporting, and enhancing the experience for...

In recent months, multiple law firms have filed securities class action lawsuits against PROCEPT BioRobotics, alleging that undisclosed discounting programs inflated reported handpiece sales, revenues, and customer inventory levels between February 2024 and February 2026. The core allegation is that late-quarter bulk discounts pulled future demand forward and were not fully disclosed to investors, raising fresh questions about the quality and sustainability of the company’s reported growth...